Literature DB >> 21228277

Structure of ubiquitin-fold modifier 1-specific protease UfSP2.

Byung Hak Ha1, Young Joo Jeon, Sang Chul Shin, Kanako Tatsumi, Masaaki Komatsu, Keiji Tanaka, Christopher M Watson, Gillian Wallis, Chin Ha Chung, Eunice EunKyeong Kim.   

Abstract

Ubiquitin-fold modifier 1 (Ufm1)-specific protease 2 (UfSP2) is a cysteine protease that is responsible for the release of Ufm1 from Ufm1-conjugated cellular proteins, as well as for the generation of mature Ufm1 from its precursor. The 2.6 Å resolution crystal structure of mouse UfSP2 reveals that it is composed of two domains. The C-terminal catalytic domain is similar to UfSP1 with Cys(294), Asp(418), His(420), Tyr(282), and a regulatory loop participating in catalysis. The novel N-terminal domain shows a unique structure and plays a role in the recognition of its cellular substrate C20orf116 and thus in the recruitment of UfSP2 to the endoplasmic reticulum, where C20orf116 predominantly localizes. Mutagenesis studies were carried out to provide the structural basis for understanding the loss of catalytic activity observed in a recently identified UfSP2 mutation that is associated with an autosomal dominant form of hip dysplasia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228277      PMCID: PMC3060479          DOI: 10.1074/jbc.M110.172171

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Molecular dissection of autophagy: two ubiquitin-like systems.

Authors:  Y Ohsumi
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  Cysteine Proteases and Their Inhibitors.

Authors:  Hans-Hartwig Otto; Tanja Schirmeister
Journal:  Chem Rev       Date:  1997-02-05       Impact factor: 60.622

Review 3.  Serine protease mechanism and specificity.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  Correlated phasing of multiple isomorphous replacement data.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1996-07-01

6.  Autosomal dominant (Beukes) premature degenerative osteoarthropathy of the hip joint maps to an 11-cM region on chromosome 4q35.

Authors:  P Roby; S Eyre; J Worthington; R Ramesar; H Cilliers; P Beighton; M Grant; G Wallis
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

7.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

8.  A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier.

Authors:  Masaaki Komatsu; Tomoki Chiba; Kanako Tatsumi; Shun-ichiro Iemura; Isei Tanida; Noriko Okazaki; Takashi Ueno; Eiki Kominami; Tohru Natsume; Keiji Tanaka
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

9.  Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.

Authors:  Min Hu; Pingwei Li; Muyang Li; Wenyu Li; Tingting Yao; Jia-Wei Wu; Wei Gu; Robert E Cohen; Yigong Shi
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

10.  Maximum-likelihood density modification.

Authors:  T C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-08
View more
  21 in total

1.  Ribosomal protein RPL26 is the principal target of UFMylation.

Authors:  Christopher P Walczak; Dara E Leto; Lichao Zhang; Celeste Riepe; Ryan Y Muller; Paul A DaRosa; Nicholas T Ingolia; Joshua E Elias; Ron R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-09       Impact factor: 11.205

Review 2.  The UFMylation System in Proteostasis and Beyond.

Authors:  Yannis Gerakis; Michaela Quintero; Honglin Li; Claudio Hetz
Journal:  Trends Cell Biol       Date:  2019-11-06       Impact factor: 20.808

3.  DDRGK1 is required for the proper development and maintenance of the growth plate cartilage.

Authors:  Monika Weisz-Hubshman; Adetutu T Egunsula; Brian Dawson; Alexis Castellon; Ming-Ming Jiang; Yuqing Chen-Evenson; Yu Zhiyin; Brendan Lee; Yangjin Bae
Journal:  Hum Mol Genet       Date:  2022-08-23       Impact factor: 5.121

4.  Deletion of ubiquitin fold modifier protein Ufm1 processing peptidase Ufsp in L. donovani abolishes Ufm1 processing and alters pathogenesis.

Authors:  Sreenivas Gannavaram; Sonya Davey; Ines Lakhal-Naouar; Robert Duncan; Hira L Nakhasi
Journal:  PLoS Negl Trop Dis       Date:  2014-02-20

5.  The ubiquitin-fold modifier 1 (Ufm1) cascade of Caenorhabditis elegans.

Authors:  Patrick Hertel; Jens Daniel; Dirk Stegehake; Hannah Vaupel; Sareetha Kailayangiri; Clio Gruel; Christian Woltersdorf; Eva Liebau
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

6.  Mechanistic study of Uba5 enzyme and the Ufm1 conjugation pathway.

Authors:  James M Gavin; Kara Hoar; Qing Xu; Jingya Ma; Yafang Lin; Jiejin Chen; Wei Chen; Frank J Bruzzese; Sean Harrison; William D Mallender; Nancy J Bump; Michael D Sintchak; Neil F Bence; Ping Li; Lawrence R Dick; Alexandra E Gould; Jesse J Chen
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

Review 7.  Update on molecular biomarkers for diagnosis and prediction of prognosis and treatment responses in gastric cancer.

Authors:  Masahiro Sasahara; Mitsuro Kanda; Yasuhiro Kodera
Journal:  Histol Histopathol       Date:  2021-03-09       Impact factor: 2.303

8.  An ER complex of ODR-4 and ODR-8/Ufm1 specific protease 2 promotes GPCR maturation by a Ufm1-independent mechanism.

Authors:  Changchun Chen; Eisuke Itakura; Katherine P Weber; Ramanujan S Hegde; Mario de Bono
Journal:  PLoS Genet       Date:  2014-03-06       Impact factor: 5.917

9.  The ufm1 cascade.

Authors:  Jens Daniel; Eva Liebau
Journal:  Cells       Date:  2014-06-11       Impact factor: 6.600

Review 10.  Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer.

Authors:  Hee Min Yoo; Jong Ho Park; Young Joo Jeon; Chin Ha Chung
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.